As of 2024-12-12, the Relative Valuation of Valbiotis SA (ALVAL.PA) is (16.49) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 EUR, the upside of Valbiotis SA based on Relative Valuation is -1325.4%.
The range of the Relative Valuation is (15.58) - (17.25) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.4x - 30.4x | 28.4x |
| Forward P/E multiples | 27.5x - 32.1x | 29.8x |
| Fair Price | (15.58) - (17.25) | (16.49) |
| Upside | -1257.2% - -1381.9% | -1325.4% |
| Date | P/E |
| 2024-12-10 | -2.37 |
| 2024-12-09 | -2.43 |
| 2024-12-06 | -2.28 |
| 2024-12-05 | -2.27 |
| 2024-12-04 | -2.36 |
| 2024-12-03 | -2.31 |
| 2024-12-02 | -2.41 |
| 2024-11-29 | -2.47 |
| 2024-11-28 | -2.09 |
| 2024-11-27 | -2.12 |
| 2024-11-26 | -2.15 |
| 2024-11-25 | -2.18 |
| 2024-11-22 | -2.18 |
| 2024-11-21 | -2.18 |
| 2024-11-20 | -2.21 |
| 2024-11-19 | -2.14 |
| 2024-11-18 | -2.20 |
| 2024-11-15 | -2.22 |
| 2024-11-14 | -2.28 |
| 2024-11-13 | -2.08 |
| 2024-11-12 | -2.04 |
| 2024-11-11 | -2.06 |
| 2024-11-08 | -2.09 |
| 2024-11-07 | -2.12 |
| 2024-11-06 | -2.18 |
| 2024-11-05 | -2.19 |
| 2024-11-04 | -2.21 |
| 2024-11-01 | -2.26 |
| 2024-10-31 | -2.25 |
| 2024-10-30 | -2.33 |
| 2024-10-29 | -2.29 |
| 2024-10-28 | -2.32 |
| 2024-10-25 | -2.37 |
| 2024-10-24 | -2.33 |
| 2024-10-23 | -2.35 |
| 2024-10-22 | -2.46 |
| 2024-10-21 | -2.28 |
| 2024-10-18 | -2.30 |
| 2024-10-17 | -2.31 |
| 2024-10-16 | -2.44 |
| 2024-10-15 | -2.24 |
| 2024-10-14 | -2.26 |
| 2024-10-11 | -2.31 |
| 2024-10-10 | -2.33 |
| 2024-10-09 | -2.21 |
| 2024-10-08 | -2.22 |
| 2024-10-07 | -2.20 |
| 2024-10-04 | -2.19 |
| 2024-10-03 | -2.17 |
| 2024-10-02 | -2.24 |